Drug turns patients into gambling addicts

Sep 18, 2006

Scottish researchers have found that drugs used to treat Parkinson's disease appear to turn some patients into gambling addicts.

A survey of patients in western Scotland found that about 10 percent of those taking dopamine agents had become problem gamblers, The Scotsman reported. A research team from Southern General Hospital in Glasgow tracked 251 Parkinson's patients who were taking different drug combinations.

Many of the patients who became addicted were already regular bettors before they went on Parkinson's medication. But the increase was often dramatic, like the patient who went from spending 10 pounds a week gambling to 1,500 pounds a week.

Parkinson's patients appear to suffer from low levels of dopamine. Dopamine plays a role in addiction by helping the brain to recognize sources of pleasure.

Robert Brown, a Glasgow psychologist, said that what patients using dopamine are likely to turn to depends on what they have access to.

"There is a tradition of gambling across the whole of Scotland, with more gamblers per head of population than in England and Wales," Brown said. "But people on these drugs could equally turn to alcohol or other ways of finding arousal or escape."

Copyright 2006 by United Press International

Explore further: FDA OKs Cubist antibiotic for serious infections

add to favorites email to friend print save as pdf

Related Stories

Parkinson's patients' 'risky behavior' explained

Jun 23, 2010

Scientists at UCL (University College London) have explained Parkinson's patients' risky behaviour, a rare side effect of standard treatments for the disease. The finding has implications for future medication of patients.

Recommended for you

FDA OKs Cubist antibiotic for serious infections

Dec 20, 2014

The Food and Drug Administration has approved a new medicine to fight complex infections in the abdomen and urinary tract, the fourth antibiotic the agency has approved since May.

Xtoro approved for swimmer's ear

Dec 18, 2014

(HealthDay)—Xtoro (finafloxacin otic suspension) eardrops have been approved by the U.S. Food and Drug Administration to treat swimmer's ear, clinically known as acute otitis externa.

Drug interaction identified for ondansetron, tramadol

Dec 18, 2014

(HealthDay)—In the early postoperative period, ondansetron is associated with increased requirements for tramadol consumption, according to a review and meta-analysis published online Dec. 10 in Anaesthesia.

New system targets germs in donated blood plasma

Dec 17, 2014

(HealthDay)—A new system designed to eliminate germs in donated blood plasma and reduce the risk of transmitting a plasma-borne infection has been approved by the U.S. Food and Drug Administration.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.